XML 54 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income (loss) $ 263.1 $ (1,010.9) $ (1,550.3)
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 133.2 132.9 127.3
Amortization of intangible assets 189.6 197.9 189.1
Amortization of deferred financing costs 2.7 2.7 2.6
Fixed asset impairment 33.4 0.0 0.0
Goodwill impairment 0.0 1,085.8 1,650.9
Indefinite-lived intangible asset impairment 5.3 179.2 346.7
Definite-lived intangible asset impairment 3.8 0.0 0.0
Deferred income taxes (37.4) (62.0) (143.8)
Stock based compensation expense 66.2 21.0 48.0
Restructuring and other costs - non-cash 16.1 22.5 64.7
Gain on sale of equity security 0.0 (44.1) 0.0
Other non-cash (income) expense (20.3) 3.4 9.9
Loss on disposal of property, plant and equipment 3.6 4.6 1.6
Gain on divestiture of noncontrolling interest (8.7) 0.0 0.0
Loss on sale on non-strategic businesses and product lines (2.0) 0.0 0.0
Changes in operating assets and liabilities, net of acquisitions:      
Accounts and notes receivable-trade, net (91.4) 23.5 (63.4)
Inventories, net 13.7 (19.9) (62.9)
Prepaid expenses and other current assets, net 13.0 (27.1) (75.0)
Other noncurrent assets, net (8.5) (12.7) (3.7)
Accounts payable 26.1 7.1 44.2
Accrued liabilities 45.3 0.3 28.3
Income taxes (15.8) 12.1 (20.5)
Other noncurrent liabilities (2.2) (16.5) 8.2
Net cash provided by operating activities 632.8 499.8 601.9
Cash flows from investing activities:      
Cash paid for acquisitions of businesses and equity investments, net of cash acquired (3.2) (130.5) (145.9)
Cash received on sale of non-strategic businesses or product lines 11.6 0.0 0.0
Purchases of short term investments 0.0 (3.7) (2.5)
Liquidation of short term investments 1.0 0.0 0.0
Capital expenditures (122.9) (182.5) (144.3)
Purchase of company owned life insurance policies 0.0 0.0 (0.9)
Cash received on derivative contracts 40.3 8.0 6.5
Cash paid on derivative contracts 0.0 (2.4) 0.0
Expenditures for identifiable intangible assets 0.0 (5.5) (6.7)
Proceeds from the sale of equity security 0.0 54.1 0.0
Proceeds from sale of property, plant and equipment, net 4.8 9.2 7.4
Net cash used in investing activities (68.4) (253.3) (286.4)
Cash flows from financing activities:      
Proceeds from long-term borrowings, net of deferred financing costs 118.9 0.1 3.1
Repayments on long-term borrowings, net (251.2) (9.4) (16.7)
Net (repayments) borrowings on short-term borrowings (68.5) 60.4 10.2
Proceeds from exercised stock options 108.8 27.9 82.3
Cash paid for contingent consideration on prior acquisitions (33.2) 0.0 0.0
Cash paid for treasury stock (260.0) (250.2) (401.4)
Cash dividends paid (80.9) (78.6) (78.3)
Net cash used in financing activities (466.1) (249.8) (400.8)
Effect of exchange rate changes on cash and cash equivalents (3.0) (7.7) 22.0
Net increase (decrease) in cash and cash equivalents 95.3 (11.0) (63.3)
Cash and cash equivalents at beginning of period 309.6 320.6 383.9
Cash and cash equivalents at end of period 404.9 309.6 320.6
Supplemental disclosures of cash flow information:      
Interest paid, net of amounts capitalized 30.2 35.1 37.0
Income taxes paid, net of refunds 112.1 104.7 122.7
Non-cash investing activities:      
Property, plant and equipment in accounts payable at end of period 13.8 14.6 12.8
Exchange of inventory for naming rights $ 3.2 $ 0.0 $ 0.0